Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 4827

1.

Prediction of early colorectal cancer metastasis by machine learning using digital slide images.

Takamatsu M, Yamamoto N, Kawachi H, Chino A, Saito S, Ueno M, Ishikawa Y, Takazawa Y, Takeuchi K.

Comput Methods Programs Biomed. 2019 Sep;178:155-161. doi: 10.1016/j.cmpb.2019.06.022. Epub 2019 Jun 22.

PMID:
31416544
2.

Endoscopic features of esophageal adenocarcinoma derived from short-segment versus long-segment Barrett's esophagus.

Yamasaki A, Shimizu T, Kawachi H, Yamamoto N, Yoshimizu S, Horiuchi Y, Ishiyama A, Yoshio T, Hirasawa T, Tsuchida T, Sasaki Y, Fujisaki J.

J Gastroenterol Hepatol. 2019 Aug 8. doi: 10.1111/jgh.14827. [Epub ahead of print]

PMID:
31396997
3.

Antioxidant capacity of soymilk yogurt and exopolysaccharides produced by lactic acid bacteria.

Yamamoto N, Shoji M, Hoshigami H, Watanabe K, Watanabe K, Takatsuzu T, Yasuda S, Igoshi K, Kinoshita H.

Biosci Microbiota Food Health. 2019;38(3):97-104. doi: 10.12938/bmfh.18-017. Epub 2019 Mar 22.

4.

Summary of the Japanese Respiratory Society statement for the treatment of lung cancer with comorbid interstitial pneumonia.

Ogura T, Takigawa N, Tomii K, Kishi K, Inoue Y, Ichihara E, Homma S, Takahashi K, Akamatsu H, Ikeda S, Inase N, Iwasawa T, Ohe Y, Ohta H, Onishi H, Okamoto I, Ogawa K, Kasahara K, Karata H, Kishimoto T, Kitamura Y, Gemma A, Kenmotsu H, Sakashita H, Sakamoto S, Sekine K, Takiguchi Y, Tada Y, Toyooka S, Nakayama Y, Nishioka Y, Hagiwara K, Hanibuchi M, Fukuoka J, Minegishi Y, Yanagihara T, Yamamoto N, Yamamoto H, Gaga M, Fong KM, Powell CA, Kiura K; DLD/TO Assemblies of JRS.

Respir Investig. 2019 Jul 31. pii: S2212-5345(18)30312-5. doi: 10.1016/j.resinv.2019.06.001. [Epub ahead of print] Review.

PMID:
31377122
5.

Essential structure of orexin 1 receptor antagonist YNT-707, Part IV: The role of D-ring in 4,5-epoxymorphinan on the orexin 1 receptor antagonistic activity.

Saitoh T, Seki K, Nakajima R, Yamamoto N, Kutsumura N, Nagumo Y, Irukayama-Tomobe Y, Ogawa Y, Ishikawa Y, Tanimura R, Yanagisawa M, Nagase H.

Bioorg Med Chem Lett. 2019 Jul 24. pii: S0960-894X(19)30495-0. doi: 10.1016/j.bmcl.2019.07.039. [Epub ahead of print]

PMID:
31375290
6.

Impact of tumor microenvironment on the efficacy of EGFR-TKIs in patients with EGFR-mutant non-small cell lung cancer.

Matsumoto Y, Sawa K, Fukui M, Oyanagi J, Izumi M, Ogawa K, Suzumura T, Watanabe T, Kaneda H, Mitsuoka S, Asai K, Kimura T, Yamamoto N, Koh Y, Kawaguchi T.

Cancer Sci. 2019 Aug 1. doi: 10.1111/cas.14156. [Epub ahead of print]

7.

Additive Effect of Magnifying Endoscopy with Narrow-Band Imaging for Diagnosing Mixed-Type Early Gastric Cancers.

Horiuchi Y, Tokai Y, Yamamoto N, Yoshimizu S, Ishiyama A, Yoshio T, Hirasawa T, Yamamoto Y, Nagahama M, Takahashi H, Tsuchida T, Fujisaki J.

Dig Dis Sci. 2019 Jul 31. doi: 10.1007/s10620-019-05762-9. [Epub ahead of print]

PMID:
31367881
8.

Sorafenib and Palbociclib Combination Regresses a Cisplatinum-resistant Osteosarcoma in a PDOX Mouse Model.

Higuchi T, Sugisawa N, Miyake K, Oshiro H, Yamamoto N, Hayashi K, Kimura H, Miwa S, Igarashi K, Chawla SP, Bouvet M, Singh SR, Tsuchiya H, Hoffman RM.

Anticancer Res. 2019 Aug;39(8):4079-4084. doi: 10.21873/anticanres.13565.

PMID:
31366491
9.

Pattern analysis suggests that phosphoenolpyruvate carboxylase in maturing soybean seeds promotes the accumulation of protein.

Yamamoto N, Masumura T, Yano K, Sugimoto T.

Biosci Biotechnol Biochem. 2019 Jul 31:1-6. doi: 10.1080/09168451.2019.1648205. [Epub ahead of print]

PMID:
31362593
10.

Acute Aspirin Plus Cilostazol Dual Therapy for Noncardioembolic Stroke Patients Within 48 Hours of Symptom Onset.

Aoki J, Iguchi Y, Urabe T, Yamagami H, Todo K, Fujimoto S, Idomari K, Kaneko N, Iwanaga T, Terasaki T, Tanaka R, Yamamoto N, Tsujino A, Nomura K, Abe K, Uno M, Okada Y, Matsuoka H, Yamagata S, Yamamoto Y, Yonehara T, Inoue T, Yagita Y, Kimura K; ADS Investigators.

J Am Heart Assoc. 2019 Aug 6;8(15):e012652. doi: 10.1161/JAHA.119.012652. Epub 2019 Jul 26.

11.

CpG ODN G9.1 as a novel nasal ODN adjuvant elicits complete protection from influenza virus infection without causing inflammatory immune responses.

Tateishi K, Fujihashi K, Yamamoto N, Hasegawa H, Ainai A, Sato K, Iho S, Yamamoto S, Maeyama JI, Odagiri T, Asanuma H.

Vaccine. 2019 Aug 23;37(36):5382-5389. doi: 10.1016/j.vaccine.2019.07.032. Epub 2019 Jul 22.

PMID:
31345642
12.

Prognostic value of metastatic lymph node regression grade after neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer.

Tominaga T, Akiyoshi T, Yamamoto N, Oba K, Nagasaki T, Yamaguchi T, Konishi T, Fukunaga Y, Ueno M.

Surgery. 2019 Jul 22. pii: S0039-6060(19)30348-4. doi: 10.1016/j.surg.2019.06.009. [Epub ahead of print]

PMID:
31345564
13.

[Association between fear of falling and activities of daily living among community-dwelling Japanese older adults].

Tomita Y, Arima K, Kawashiri SY, Tsujimoto R, Kanagae M, Mizukami S, Okabe T, Yamamoto N, Ohmachi I, Nakahara K, Nishimura T, Abe Y, Aoyagi K.

Nihon Koshu Eisei Zasshi. 2019;66(7):341-347. doi: 10.11236/jph.66.7_341. Japanese.

14.

Low-Frequency Electrical Stimulation of Denervated Skeletal Muscle Retards Muscle and Trabecular Bone Loss in Aged Rats.

Tamaki H, Yotani K, Ogita F, Hayao K, Kirimto H, Onishi H, Kasuga N, Yamamoto N.

Int J Med Sci. 2019 Jun 2;16(6):822-830. doi: 10.7150/ijms.32590. eCollection 2019.

15.

Dark-Field Scattering and Local SERS Mapping from Plasmonic Aluminum Bowtie Antenna Array.

Dao TD, Hoang CV, Nishio N, Yamamoto N, Ohi A, Nabatame T, Aono M, Nagao T.

Micromachines (Basel). 2019 Jul 13;10(7). pii: E468. doi: 10.3390/mi10070468.

16.

Role of Reelin in cell positioning in the cerebellum and the cerebellum-like structure in zebrafish.

Nimura T, Itoh T, Hagio H, Hayashi T, Di Donato V, Takeuchi M, Itoh T, Inoguchi F, Sato Y, Yamamoto N, Katsuyama Y, Del Bene F, Shimizu T, Hibi M.

Dev Biol. 2019 Jul 16. pii: S0012-1606(19)30049-1. doi: 10.1016/j.ydbio.2019.07.010. [Epub ahead of print]

PMID:
31323192
17.

Relationship between muscle-strengthening activities recommended by physical activity guidelines and knee extensor strength in the elderly.

Yamamoto N, Kawakami T, Hongu N, Asai H, Hagi Y.

J Phys Ther Sci. 2019 Jun;31(6):482-487. doi: 10.1589/jpts.31.482. Epub 2019 Jun 1.

18.

First prospective feasibility study of carbon-ion radiotherapy using compact superconducting rotating gantry.

Bhattacharyya T, Koto M, Ikawa H, Hayashi K, Hagiwara Y, Makishima H, Kasuya G, Yamamoto N, Kamada T, Tsuji H.

Br J Radiol. 2019 Jul 24:20190370. doi: 10.1259/bjr.20190370. [Epub ahead of print]

PMID:
31317764
19.

Surgical treatment of chondroblastoma using extended intralesional curettage with phenol as a local adjuvant.

Zekry KM, Yamamoto N, Hayashi K, Takeuchi A, Araki Y, Alkhooly AZA, Abd-Elfattah AS, Fouly EH, Elsaid ANS, Tsuchiya H.

J Orthop Surg (Hong Kong). 2019 Sep-Dec;27(3):2309499019861031. doi: 10.1177/2309499019861031.

PMID:
31315494
20.

Caffeine citrate enhanced cisplatin antitumor effects in osteosarcoma and fibrosarcoma in vitro and in vivo.

Abe K, Yamamoto N, Hayashi K, Takeuchi A, Tsuchiya H.

BMC Cancer. 2019 Jul 15;19(1):689. doi: 10.1186/s12885-019-5891-y.

21.

C-arm cone-beam computed tomography-guided minimally invasive open excision of an osteoid osteoma undetectable on fluoroscopy: A case report.

Higuchi T, Yamamoto N, Hayashi K, Takeuchi A, Abe K, Taniguchi Y, Araki Y, Tsuchiya H.

Int J Surg Case Rep. 2019 Jul 8;61:14-19. doi: 10.1016/j.ijscr.2019.06.062. [Epub ahead of print]

22.

The Combination of Olaratumab with Doxorubicin and Cisplatinum Regresses a Chemotherapy-Resistant Osteosarcoma in a Patient-Derived Orthotopic Xenograft Mouse Model.

Higuchi T, Sugisawa N, Miyake K, Oshiro H, Yamamoto N, Hayashi K, Kimura H, Miwa S, Igarashi K, Bouvet M, Singh SR, Tsuchiya H, Hoffman RM.

Transl Oncol. 2019 Sep;12(9):1257-1263. doi: 10.1016/j.tranon.2019.06.002. Epub 2019 Jul 9.

23.

An easy and reliable method to close Petersen's defect using barbed suture to prevent internal hernia from developing after gastrectomy with Roux-en-Y reconstruction.

Hara K, Hayashi T, Nakazono M, Nagasawa S, Shimoda Y, Kumazu Y, Yamada T, Yamamoto N, Shiozawa M, Morinaga S, Yoshikawa T, Rino Y, Masuda M, Ogata T, Oshima T.

Asian J Endosc Surg. 2019 Jul 12. doi: 10.1111/ases.12732. [Epub ahead of print]

PMID:
31297969
24.

Rapid screening and early precautions for carbapenem-resistant Acinetobacter baumannii carriers decreased nosocomial transmission in hospital settings: a quasi-experimental study.

Yamamoto N, Hamaguchi S, Akeda Y, Santanirand P, Chaihongsa N, Sirichot S, Chiaranaicharoen S, Hagiya H, Yamamoto K, Kerdsin A, Okada K, Yoshida H, Hamada S, Oishi K, Malathum K, Tomono K.

Antimicrob Resist Infect Control. 2019 Jun 27;8:110. doi: 10.1186/s13756-019-0564-9. eCollection 2019.

25.

Vitamin B12 deficiency anemia in an exclusively breastfed infant born to an ileum-resected mother.

Tamura A, Nino N, Yamamoto N, Naito A, Matsubara K, Nakatani N, Ichikawa T, Nakamura S, Saito A, Kozaki A, Kishimoto K, Ishida T, Shigematsu Y, Hasegawa D, Kosaka Y.

Pediatr Neonatol. 2019 Jun 11. pii: S1875-9572(19)30018-X. doi: 10.1016/j.pedneo.2019.06.002. [Epub ahead of print] No abstract available.

26.

Combination of Vaccine Strain Measles Virus and Nimotuzumab in the Treatment of Laryngeal Cancer.

Toan NL, Hang NT, Luu NK, VAN Mao C, VAN Ba N, Xuan NT, Cam TD, Yamamoto N, VAN Tong H, Son HA.

Anticancer Res. 2019 Jul;39(7):3727-3737. doi: 10.21873/anticanres.13521.

PMID:
31262899
27.

A minimum of 100 tumor cells in a single biopsy sample is required to assess programmed cell death ligand 1 expression in predicting patient response to nivolumab treatment in non-squamous non-small cell lung carcinoma.

Naito T, Udagawa H, Sato J, Horinouchi H, Murakami S, Goto Y, Kanda S, Fujiwara Y, Yamamoto N, Zenke Y, Kirita K, Matsumoto S, Yoh K, Niho S, Motoi N, Ohe Y, Ishii G, Goto K.

J Thorac Oncol. 2019 Jun 28. pii: S1556-0864(19)30501-5. doi: 10.1016/j.jtho.2019.06.019. [Epub ahead of print]

PMID:
31260834
28.

In Which Arm Position Is a Hill-Sachs Lesion Created?

Kawakami J, Yamamoto N, Hatta T, Shinagawa K, Itoi E.

Am J Sports Med. 2019 Aug;47(10):2464-2468. doi: 10.1177/0363546519858418. Epub 2019 Jun 27.

PMID:
31246498
29.

A patient with Nivolumab-related Fulminant Type 1 Diabetes Mellitus whose Serum C-peptide Level Was Preserved at the Initial Detection of Hyperglycemia.

Yamamoto N, Tsurutani Y, Katsuragawa S, Kubo H, Sunouchi T, Hirose R, Hoshino Y, Ichikawa M, Takiguchi T, Yukawa H, Arioka H, Saitou J, Nishikawa T.

Intern Med. 2019 Jun 27. doi: 10.2169/internalmedicine.2780-19. [Epub ahead of print]

30.

Phase I/II study of intermitted erlotinib in combination with docetaxel in patients with recurrent non-small cell lung cancer (WJOG4708L).

Kimura T, Kawaguchi T, Chiba Y, Yoshioka H, Watanabe K, Kijima T, Kogure Y, Oguri T, Yoshimura N, Niwa T, Kasai T, Hayashi H, Ono A, Asai K, Tanaka H, Yano S, Yamamoto N, Nakanishi Y, Nakagawa K.

Jpn J Clin Oncol. 2019 Jun 26. pii: hyz088. doi: 10.1093/jjco/hyz088. [Epub ahead of print]

PMID:
31242302
31.

Correction to: Real-world treatment of over 1600 Japanese patients with EGFR mutation-positive non-small cell lung cancer with daily afatinib.

Tamura K, Nukiwa T, Gemma A, Yamamoto N, Mizushima M, Ochai K, Ikeda R, Azuma H, Nakanishi Y.

Int J Clin Oncol. 2019 Sep;24(9):1169. doi: 10.1007/s10147-019-01488-w.

PMID:
31240497
32.

Aligned carbon nanotube morphogenesis predicts physical properties of their polymer nanocomposites.

Natarajan B, Stein IY, Lachman N, Yamamoto N, Jacobs DS, Sharma R, Liddle JA, Wardle BL.

Nanoscale. 2019 Jun 24. doi: 10.1039/c9nr03317c. [Epub ahead of print]

PMID:
31233061
33.

Pazopanib maintenance therapy after tandem high-dose chemotherapy for disseminated Ewing sarcoma.

Tamura A, Yamamoto N, Nino N, Ichikawa T, Nakatani N, Nakamura S, Saito A, Kozaki A, Kishimoto K, Ishida T, Yoshida M, Akasaka Y, Hasegawa D, Kosaka Y.

Int Cancer Conf J. 2019 Feb 14;8(3):95-100. doi: 10.1007/s13691-019-00362-w. eCollection 2019 Jul.

PMID:
31218182
34.

Home safety practices to prevent child injury and its association with family and children's daily routines in Japan: A cross-sectional study.

Honda C, Naruse T, Tsuchiya-Ito R, Yamamoto N, Nagata S.

Jpn J Nurs Sci. 2019 Jun 19. doi: 10.1111/jjns.12274. [Epub ahead of print]

PMID:
31216107
35.

Dynamics of Minimal Residual Disease in Neuroblastoma Patients.

Uemura S, Ishida T, Thwin KKM, Yamamoto N, Tamura A, Kishimoto K, Hasegawa D, Kosaka Y, Nino N, Lin KS, Takafuji S, Mori T, Iijima K, Nishimura N.

Front Oncol. 2019 Jun 4;9:455. doi: 10.3389/fonc.2019.00455. eCollection 2019. Review.

36.

Development of a Noninvasive Skin Evaluation Method for Lower Limb Lymphedema.

Sano M, Hirakawa S, Yamanaka Y, Naruse E, Inuzuka K, Saito T, Katahashi K, Yata T, Kayama T, Tsuyuki H, Yamamoto N, Takeuchi H, Unno N.

Lymphat Res Biol. 2019 Jun 18. doi: 10.1089/lrb.2018.0089. [Epub ahead of print]

PMID:
31211932
37.

Immunogenomic profiles associated with response to neoadjuvant chemoradiotherapy in patients with rectal cancer.

Akiyoshi T, Tanaka N, Kiyotani K, Gotoh O, Yamamoto N, Oba K, Fukunaga Y, Ueno M, Mori S.

Br J Surg. 2019 Sep;106(10):1381-1392. doi: 10.1002/bjs.11179. Epub 2019 Jun 13.

PMID:
31197828
38.

Feasibility of genomic profiling with next-generation sequencing using specimens obtained by image-guided percutaneous needle biopsy.

Sone M, Arai Y, Sugawara S, Kubo T, Itou C, Hasegawa T, Umakoshi N, Yamamoto N, Sunami K, Hiraoka N, Kubo T.

Ups J Med Sci. 2019 Apr;124(2):119-124. doi: 10.1080/03009734.2019.1607635.

39.

Difference in central nerve system metastasis during gefitinib or erlotinib therapy in patients with EGFR-mutated non-small cell lung cancer: a retrospective study.

Yoshida K, Kanda S, Shiraishi H, Goto K, Itahashi K, Goto Y, Horinouchi H, Fujiwara Y, Nokihara H, Yamamoto N, Ohe Y.

J Thorac Dis. 2019 Apr;11(4):1347-1354. doi: 10.21037/jtd.2019.03.61.

40.

A case of mediastinitis with an exposed artificial blood vessel that was associated with right ventricular wall damage during treatment.

Yoshida R, Yamamoto N, Nishijima A, Maruyama E, Takikawa M, Yanagibayashi S.

Case Reports Plast Surg Hand Surg. 2019 May 10;6(1):55-59. doi: 10.1080/23320885.2019.1611435. eCollection 2019.

41.

NUPR1 acts as a pro-survival factor in human bone marrow-derived mesenchymal stem cells and is induced by the hypoxia mimetic reagent deferoxamine.

Matsunaga K, Fujisawa K, Takami T, Burganova G, Sasai N, Matsumoto T, Yamamoto N, Sakaida I.

J Clin Biochem Nutr. 2019 May;64(3):209-216. doi: 10.3164/jcbn.18-112. Epub 2019 Mar 23.

42.

Structural Insights into the Inhibition of Amyloid Fibril Formation by Fibrinogen via Interaction with Prefibrillar Intermediates.

Yamamoto N, Akai T, Inoue R, Sugiyama M, Tamura A, Chatani E.

Biochemistry. 2019 Jun 18;58(24):2769-2781. doi: 10.1021/acs.biochem.9b00439. Epub 2019 Jun 5.

PMID:
31135143
43.

Pazopanib regresses a doxorubicin-resistant synovial sarcoma in a patient-derived orthotopic xenograft mouse model.

Igarashi K, Kawaguchi K, Kiyuna T, Miyake K, Miyake M, Nelson SD, Russell TA, Dry SM, Li Y, Yamamoto N, Hayashi K, Kimura H, Miwa S, Higuchi T, Singh SR, Tsuchiya H, Hoffman RM.

Tissue Cell. 2019 Jun;58:107-111. doi: 10.1016/j.tice.2019.04.010. Epub 2019 May 3.

PMID:
31133237
44.

Phase I study of the indoleamine 2,3-dioxygenase 1 inhibitor navoximod (GDC-0919) as monotherapy and in combination with the PD-L1 inhibitor atezolizumab in Japanese patients with advanced solid tumours.

Ebata T, Shimizu T, Fujiwara Y, Tamura K, Kondo S, Iwasa S, Yonemori K, Shimomura A, Kitano S, Koyama T, Sato N, Nakai K, Inatani M, Yamamoto N.

Invest New Drugs. 2019 May 24. doi: 10.1007/s10637-019-00787-3. [Epub ahead of print]

PMID:
31124055
45.

Cytokine expression profiles in cervical mucus from patients with cervical cancer and its precursor lesions.

Otani S, Fujii T, Kukimoto I, Yamamoto N, Tsukamoto T, Ichikawa R, Nishio E, Iwata A.

Cytokine. 2019 Aug;120:210-219. doi: 10.1016/j.cyto.2019.05.011. Epub 2019 May 20.

46.

Association of Adverse Drug Events with Broad-spectrum Antibiotic Use in Hospitalized Patients: A Single-center Study.

Hagiya H, Kokado R, Ueda A, Okuno H, Morii D, Hamaguchi S, Yamamoto N, Yoshida H, Tomono K.

Intern Med. 2019 May 22. doi: 10.2169/internalmedicine.2603-18. [Epub ahead of print]

47.

Preparation of Induced Pluripotent Stem Cells Using Human Peripheral Blood Monocytes.

Isogai S, Yamamoto N, Hiramatsu N, Goto Y, Hayashi M, Kondo M, Imaizumi K.

Cell Reprogram. 2018 Dec;20(6):347-355. doi: 10.1089/cell.2018.0024.

48.

Peritoneal dissemination of ascending colon cancer demonstrating relapse-free survival for 40 months with panitumumab monotherapy: A case report.

Tokuhara K, Yamamoto N, Hishikawa H, Yoshioka K.

Int J Surg Case Rep. 2019;59:41-45. doi: 10.1016/j.ijscr.2019.05.001. Epub 2019 May 9.

49.

Sequencing of therapy following first-line afatinib in patients with EGFR mutation-positive non-small cell lung cancer.

Park K, Bennouna J, Boyer M, Hida T, Hirsh V, Kato T, Lu S, Mok T, Nakagawa K, O'Byrne K, Paz-Ares L, Schuler M, Sibilot DM, Tan EH, Tanaka H, Wu YL, Yang JC, Zhang L, Zhou C, Märten A, Tang W, Yamamoto N.

Lung Cancer. 2019 Jun;132:126-131. doi: 10.1016/j.lungcan.2019.04.014. Epub 2019 Apr 10.

50.

Predictive value of serum protein levels in patients with advanced non-small cell lung cancer treated with nivolumab.

Oyanagi J, Koh Y, Sato K, Mori K, Teraoka S, Akamatsu H, Kanai K, Hayata A, Tokudome N, Akamatsu K, Nakanishi M, Ueda H, Yamamoto N.

Lung Cancer. 2019 Jun;132:107-113. doi: 10.1016/j.lungcan.2019.03.020. Epub 2019 Mar 22.

PMID:
31097082

Supplemental Content

Loading ...
Support Center